Related Experiment Video
Updated: Jun 17, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C and evasion of the interferon system: a PKR paradigm
1Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain.
Insights
Hepatitis C virus (HCV) evades interferon treatment by activating protein kinase R. This kinase blocks the translation of essential antiviral genes, hindering the body's immune response.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) infection poses a significant clinical challenge due to its resistance to type I interferon, a crucial antiviral cytokine.
- Understanding the mechanisms by which HCV evades host antiviral defenses is critical for developing effective therapies.
Discussion:
- HCV employs a sophisticated strategy to counteract interferon-induced antiviral activity.
- The study identifies the ds-RNA-dependent protein kinase R (PKR) as a key mediator in HCV's evasion tactics.
Key Insights:
- HCV activates PKR, which subsequently phosphorylates and inhibits the translation initiation factor eIF-2 alpha.
- This inhibition effectively blocks the translation of interferon-stimulated genes, thereby suppressing the host's antiviral response.
Outlook:
- Targeting the PKR-eIF-2 alpha pathway could represent a novel therapeutic strategy against HCV.
- Further research into HCV's molecular interactions with host cell machinery may reveal new avenues for antiviral drug development.
Abstract:
Hepatitis C virus (HCV) is resistant to the antiviral cytokine type I interferon, representing a major clinical problem. Garaigorta and Chisari (2009) reveal that HCV uses the activation of the ds-RNA-dependent protein kinase R, which phosphorylates and inhibits the translation initiation factor eIF-2 alpha, to block translation of interferon-stimulated genes.
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
Viral Hepatitis I: Introduction
Inhibitors Of Virion Release
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

